These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16772624)

  • 1. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.
    Brouwer IA; Zock PL; Camm AJ; Böcker D; Hauer RN; Wever EF; Dullemeijer C; Ronden JE; Katan MB; Lubinski A; Buschler H; Schouten EG;
    JAMA; 2006 Jun; 295(22):2613-9. PubMed ID: 16772624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.
    Raitt MH; Connor WE; Morris C; Kron J; Halperin B; Chugh SS; McClelland J; Cook J; MacMurdy K; Swenson R; Connor SL; Gerhard G; Kraemer DF; Oseran D; Marchant C; Calhoun D; Shnider R; McAnulty J
    JAMA; 2005 Jun; 293(23):2884-91. PubMed ID: 15956633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators.
    Brouwer IA; Raitt MH; Dullemeijer C; Kraemer DF; Zock PL; Morris C; Katan MB; Connor WE; Camm JA; Schouten EG; McAnulty J
    Eur Heart J; 2009 Apr; 30(7):820-6. PubMed ID: 19196720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
    Leaf A; Albert CM; Josephson M; Steinhaus D; Kluger J; Kang JX; Cox B; Zhang H; Schoenfeld D;
    Circulation; 2005 Nov; 112(18):2762-8. PubMed ID: 16267249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia.
    Weisman D; Beinart R; Erez A; Koren-Morag N; Goldenberg I; Eldar M; Glikson M; Luria D
    J Interv Card Electrophysiol; 2017 Sep; 49(3):255-261. PubMed ID: 28664342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis.
    Jenkins DJ; Josse AR; Beyene J; Dorian P; Burr ML; LaBelle R; Kendall CW; Cunnane SC
    CMAJ; 2008 Jan; 178(2):157-64. PubMed ID: 18195289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA.
    Brouwer IA; Zock PL; Wever EF; Hauer RN; Camm AJ; Böcker D; Otto-Terlouw P; Katan MB; Schouten EG
    Eur J Clin Nutr; 2003 Oct; 57(10):1323-30. PubMed ID: 14506496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
    Billman GE
    Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
    Mozaffarian D; Marchioli R; Macchia A; Silletta MG; Ferrazzi P; Gardner TJ; Latini R; Libby P; Lombardi F; O'Gara PT; Page RL; Tavazzi L; Tognoni G;
    JAMA; 2012 Nov; 308(19):2001-11. PubMed ID: 23128104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials.
    Khoueiry G; Abi Rafeh N; Sullivan E; Saiful F; Jaffery Z; Kenigsberg DN; Krishnan SC; Khanal S; Bekheit S; Kowalski M
    Heart Lung; 2013; 42(4):251-6. PubMed ID: 23714269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Dorian P; Borggrefe M; Al-Khalidi HR; Hohnloser SH; Brum JM; Tatla DS; Brachmann J; Myerburg RJ; Cannom DS; van der Laan M; Holroyde MJ; Singer I; Pratt CM;
    Circulation; 2004 Dec; 110(24):3646-54. PubMed ID: 15533855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
    Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
    Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress.
    Nigam A; Talajic M; Roy D; Nattel S; Lambert J; Nozza A; Jones P; Ramprasath VR; O'Hara G; Kopecky S; Brophy JM; Tardif JC;
    J Am Coll Cardiol; 2014 Oct; 64(14):1441-8. PubMed ID: 25277614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease.
    Brouwer IA; Geelen A; Katan MB
    Prog Lipid Res; 2006 Jul; 45(4):357-67. PubMed ID: 16678270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.